Literature DB >> 9646229

Assessment of methods for primary tissue culture of human breast epithelia.

M V Croce1, A G Colussi, A Segal-Eiras.   

Abstract

A serie of 29 human normal, benign and malignant breast tissues were cultivated in an attempt to isolate and propagate primary breast epithelial cells in vitro. Explants methodology as well as disaggregation techniques (enzymatic and mechanical) were employed to obtain better culture conditions. Cells derived from breast malignant tissue were propagated in an appropriate and survived in culture for at least 6 months, exhibiting a marked preference to grow in suspension (independent anchorage). Tumorigenicity assays in nude mice were performed with malignant cells obtained from primary culture cells as well as with cells achieved from successive passages. The rate of long time cell survival from malignant and non-malignant tissues demonstrated the accuracy of the methodology but it also emphasised the need for improving technology to obtain cell lines with long survival.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9646229

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  3 in total

1.  A comprehensive characterization of cell cultures and xenografts derived from a human verrucous penile carcinoma.

Authors:  Juan J Muñoz; Sandra A Drigo; Hellen Kuasne; Rolando A R Villacis; Fabio A Marchi; Maria A C Domingues; Ademar Lopes; Tiago G Santos; Silvia R Rogatto
Journal:  Tumour Biol       Date:  2016-03-10

2.  Evidence for the isolation, growth, and characterization of malignant cells in primary cultures of human tumors.

Authors:  Robert L Ochs; Jeffrey Fensterer; N Paul Ohori; Alan Wells; Michael Gabrin; Lisa D George; Paul Kornblith
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Jan-Feb       Impact factor: 2.416

Review 3.  Management and potentialities of primary cancer cultures in preclinical and translational studies.

Authors:  Giacomo Miserocchi; Laura Mercatali; Chiara Liverani; Alessandro De Vita; Chiara Spadazzi; Federica Pieri; Alberto Bongiovanni; Federica Recine; Dino Amadori; Toni Ibrahim
Journal:  J Transl Med       Date:  2017-11-07       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.